recast a slight rise in sales and slightly higher adjusted EBITDA than in the previous year. Thanks to the very good development of our growth seg- ments, Nutrition & Care and Resource Efficiency, especially in the first half of the year, we raised our guidance at the end of the first and second quarters. After the first six months, we anti